NO20010464D0 - Fremgangsmåter og sammensetninger for behandling av gastroösofrageal-reflukssyndrom - Google Patents

Fremgangsmåter og sammensetninger for behandling av gastroösofrageal-reflukssyndrom

Info

Publication number
NO20010464D0
NO20010464D0 NO20010464A NO20010464A NO20010464D0 NO 20010464 D0 NO20010464 D0 NO 20010464D0 NO 20010464 A NO20010464 A NO 20010464A NO 20010464 A NO20010464 A NO 20010464A NO 20010464 D0 NO20010464 D0 NO 20010464D0
Authority
NO
Norway
Prior art keywords
gastroesophrageal
compositions
treatment
methods
reflux syndrome
Prior art date
Application number
NO20010464A
Other languages
English (en)
Other versions
NO20010464L (no
Inventor
John R Mccullough
Thomas P Jerussi
Original Assignee
Sepracor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sepracor Inc filed Critical Sepracor Inc
Publication of NO20010464D0 publication Critical patent/NO20010464D0/no
Publication of NO20010464L publication Critical patent/NO20010464L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20010464A 1998-07-28 2001-01-26 FremgangsmÕter og preparater for behandling av gastro- øsofagealt-reflukssyndrom NO20010464L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/123,892 US6147093A (en) 1996-07-19 1998-07-28 Methods for treating gastroesophageal reflux disease
PCT/US1999/016736 WO2000006165A1 (en) 1998-07-28 1999-07-23 Methods and compositions for treating gastro-esophageal reflux disease

Publications (2)

Publication Number Publication Date
NO20010464D0 true NO20010464D0 (no) 2001-01-26
NO20010464L NO20010464L (no) 2001-03-23

Family

ID=22411520

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20010464A NO20010464L (no) 1998-07-28 2001-01-26 FremgangsmÕter og preparater for behandling av gastro- øsofagealt-reflukssyndrom

Country Status (25)

Country Link
US (4) US6147093A (no)
EP (1) EP1100502A1 (no)
JP (1) JP2002521448A (no)
KR (1) KR20010071047A (no)
CN (1) CN1320036A (no)
AR (1) AR019947A1 (no)
AU (1) AU5126099A (no)
BG (1) BG105218A (no)
BR (1) BR9912581A (no)
CA (1) CA2338465A1 (no)
CO (1) CO5060499A1 (no)
CZ (1) CZ295776B6 (no)
EA (1) EA200100188A1 (no)
EE (1) EE200100051A (no)
HK (1) HK1041226A1 (no)
HR (1) HRP20010075A2 (no)
HU (1) HUP0102979A3 (no)
ID (1) ID28894A (no)
IL (1) IL141047A0 (no)
NO (1) NO20010464L (no)
NZ (1) NZ509671A (no)
PL (1) PL345764A1 (no)
SK (1) SK1202001A3 (no)
TR (1) TR200100921T2 (no)
WO (1) WO2000006165A1 (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6147093A (en) * 1996-07-19 2000-11-14 Sepracor Inc. Methods for treating gastroesophageal reflux disease
EA002362B1 (ru) * 1997-07-11 2002-04-25 Янссен Фармацевтика Н.В. Применение (+)-4-амино-5-хлор-n-(3-метокси-4-пиперидинил)-2-метоксибензамида для приготовления лекарственных препаратов для лечения заболеваний желудочно-кишечного тракта
US6353005B1 (en) 1999-03-02 2002-03-05 Sepracor, Inc. Method and compositions using (+) norcisapride in combination with proton pump inhibitors or H2 receptor antagonist
DE10314916A1 (de) 2003-04-01 2004-10-21 Endress + Hauser Flowtec Ag, Reinach Vorrichtung zur Bestimmung und/oder Überwachung des Volumen- und/oder Massenstroms eines Mediums
ATE457309T1 (de) * 2003-12-23 2010-02-15 Serodus As Modulatoren von peripheren 5-ht-rezeptoren
US8524736B2 (en) 2004-01-07 2013-09-03 Armetheon, Inc. Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
EP1704146B1 (en) * 2004-01-07 2010-04-14 Aryx Therapeutics Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
US8138204B2 (en) * 2004-01-07 2012-03-20 Aryx Therapeutics, Inc. Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
US20050160544A1 (en) * 2004-01-26 2005-07-28 Marc Geller Contoured grill brush
DK1919909T3 (da) * 2005-08-31 2013-12-02 Armetheon Inc Syntesemetoder og mellemprodukter for stereoisomere forbindelser, der er anvendelige til behandling af gastrointestinale forstyrrelser og forstyrrelser i centralnervesystemet
US20080085915A1 (en) * 2006-06-23 2008-04-10 Cyrus Becker Compounds and methods for the treatment of gastrointestinal and central nervous system disorders
US10570127B1 (en) 2018-11-05 2020-02-25 Renexxion, Llc Material and methods for the treatment of gastro-intestinal disorders

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5137896A (en) * 1981-10-01 1992-08-11 Janssen Pharmaceutica N.V. N-(3-hydroxy-4-piperidinyl)benzamide derivatives
US4962115A (en) * 1981-10-01 1990-10-09 Janssen Pharmaceutica N.V. Novel N-(3-hydroxy-4-piperidinyl)benzamide derivatives
US5057525A (en) * 1981-10-01 1991-10-15 Janssen Pharmaceutica N.V. Novel N-(3-hydroxy-4-piperidinyl) benzamide derivatives
WO1994001111A1 (en) * 1992-07-07 1994-01-20 Sepracor Inc. Methods of using (+) cisapride for the treatment of gastro-esophageal reflux disease and other disorders
CA2139638A1 (en) * 1992-07-07 1994-01-20 Nancy M. Gray Methods of using (-) cisapride for the treatment of gastro-esophageal reflux disease and other disorders
CA2166730A1 (en) * 1993-07-06 1995-01-19 Robert T. Sims H2 antagonist-gastrointestinal motility agent combinations
US5712293A (en) * 1995-06-07 1998-01-27 Sepracor, Inc. Methods for treating gastro-esophageal reflux disease and other disorders associated with the digestive tract using optically pure (-) norcisapride
US5739151A (en) * 1996-07-19 1998-04-14 Sepracor Inc. Method for treating emesis and central nervous system disorders using optically pure (+) norcisapride
US6147093A (en) * 1996-07-19 2000-11-14 Sepracor Inc. Methods for treating gastroesophageal reflux disease
EA002362B1 (ru) * 1997-07-11 2002-04-25 Янссен Фармацевтика Н.В. Применение (+)-4-амино-5-хлор-n-(3-метокси-4-пиперидинил)-2-метоксибензамида для приготовления лекарственных препаратов для лечения заболеваний желудочно-кишечного тракта

Also Published As

Publication number Publication date
HRP20010075A2 (en) 2002-02-28
EP1100502A1 (en) 2001-05-23
WO2000006165A1 (en) 2000-02-10
HK1041226A1 (zh) 2002-07-05
US20040044039A1 (en) 2004-03-04
EE200100051A (et) 2002-06-17
CA2338465A1 (en) 2000-02-10
KR20010071047A (ko) 2001-07-28
ID28894A (id) 2001-07-12
AU5126099A (en) 2000-02-21
CZ2001348A3 (cs) 2002-01-16
HUP0102979A3 (en) 2002-01-28
IL141047A0 (en) 2002-02-10
JP2002521448A (ja) 2002-07-16
PL345764A1 (en) 2002-01-02
BR9912581A (pt) 2001-05-02
AR019947A1 (es) 2002-03-27
CO5060499A1 (es) 2001-07-30
NZ509671A (en) 2003-08-29
HUP0102979A2 (hu) 2001-12-28
CN1320036A (zh) 2001-10-31
US6632827B2 (en) 2003-10-14
EA200100188A1 (ru) 2001-08-27
SK1202001A3 (en) 2001-08-06
US20010020031A1 (en) 2001-09-06
CZ295776B6 (cs) 2005-11-16
US6242465B1 (en) 2001-06-05
US6147093A (en) 2000-11-14
TR200100921T2 (tr) 2001-10-22
NO20010464L (no) 2001-03-23
BG105218A (en) 2001-11-30

Similar Documents

Publication Publication Date Title
DK1813624T3 (da) Fremgangsmåder og sammensætninger til forebyggelse og behandling af anæmi
NO20012916D0 (no) Sammensetninger og fremgangsmåter for behandling av anorektale forstyrrelser
NO20024610D0 (no) Synergistiske metoder og blandinger for behandling av kreft
NO994778L (no) Fremgangsmåter og preparater for behandling av inflammatorisk tarmsyndrom
NO20003096D0 (no) Sammensetninger og fremgangsmÕter for behandling av ADD
DK1352895T3 (da) Adamantanderivater til behandling af inflammatioriske immunologiske og kardiovaskulære sygdomme
NO20000011D0 (no) Skumdempersammensetninger og fremgangsmåter
DK1220849T3 (da) Sammensætninger med bicykliske forbindelser og fremgangsmåde til stabilisering heraf
NO20005017L (no) Metoder og viskøse sammensetninger for behandling av brønner
DE10082139T1 (de) Zusammensetzung zur Behandlung von Reibungspaaren
NO20015542L (no) Fremgangsmåte for fremstilling og anvendelse av N- desmetylzopikloner
NO985484D0 (no) FremgangsmÕte og preparat for behandling og forhindring av hyperurikemi
NO20014314L (no) Blandinger og metoder for behandling av stafylokokkisk infeksjon
NO20012963D0 (no) Fremgangsmåte for fremstilling av 3-alkanoylindoler og 3- alkylindoler
DK1165510T3 (da) 1-arensulfonyl-2-aryl-pyrrolidin- og -piperidinderivater til behandling af CNS-lidelser
NO20015772L (no) Forbindelser og fremgangsmåter for behandling av post- traumatisk stress-syndrom
NO20010464D0 (no) Fremgangsmåter og sammensetninger for behandling av gastroösofrageal-reflukssyndrom
NO20033498L (no) Fremgangsmåte for behandling og törking av trevirke
ID27214A (id) Triazolopiridina untuk pengobatan gangguan trombosis
NO20001758D0 (no) Fremgangsmåter og blandinger for behandling av leddgikt
NO20003481D0 (no) FremgangsmÕte for behandling av COPD
NO20012099D0 (no) Fremgangsmåte for fremstilling av 4-arylpiperidin-3- carbinoler og beslektede forbindelser
NO20022990L (no) Fremgangsmåte og sammensetning for behandling av smerte
EP1305017A4 (en) METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF SYNDROME X
ID29414A (id) Pengobatan depresi

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application